Exercise or conversion by Gharib Samir M of 75000 shares of Spruce BiosciencesInc subject to Rule 16b-3
SPRB Stock | USD 0.37 0.01 2.78% |
About 55% of Spruce Biosciences' investors are presently thinking to get in. The analysis of overall sentiment of trading Spruce Biosciences stock suggests that some investors are interested at this time. The current market sentiment, together with Spruce Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Spruce Biosciences stock news signals to limit their universe of possible portfolio assets.
Spruce |
Filed transaction by Spruce Biosciences Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Read at macroaxis.com
Spruce Biosciences Fundamental Analysis
We analyze Spruce Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spruce Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spruce Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Spruce Biosciences is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Spruce Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spruce Biosciences stock to make a market-neutral strategy. Peer analysis of Spruce Biosciences could also be used in its relative valuation, which is a method of valuing Spruce Biosciences by comparing valuation metrics with similar companies.
Peers
Spruce Biosciences Related Equities
ABOS | Acumen Pharmaceuticals | 7.36 | ||||
TERN | Terns Pharmaceuticals | 4.94 | ||||
ELDN | Eledon Pharmaceuticals | 2.93 | ||||
DAWN | Day One | 1.14 | ||||
HOOK | Hookipa Pharma | 2.45 | ||||
INZY | Inozyme Pharma | 3.70 | ||||
XFOR | X4 Pharmaceuticals | 3.92 |
Complementary Tools for Spruce Stock analysis
When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Transaction History View history of all your transactions and understand their impact on performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |